Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Phase II Study of Intravenous Rexin-G in Osteosarcoma

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00572130
Recruitment Status : Completed
First Posted : December 12, 2007
Last Update Posted : June 10, 2011
Information provided by:
Epeius Biotechnologies

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : July 2010
Actual Study Completion Date : June 2011